Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.24.1.u1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Compensation Expense
The following table presents a summary of the Company’s nonvested performance share units (“PSUs”) and restricted stock units (“RSUs”) for the three months ended March 31, 2024:
Awards Weighted Average Grant Date Fair Value
(in thousands)
Nonvested, at December 31, 2023
1,488  $ 8.74 
Granted —  — 
Vested (156) 9.64 
Forfeited (39) 9.44 
Nonvested, at March 31, 2024
1,293  $ 8.61 
Schedule of Stock Option Activity
The following table presents a summary of the Company’s stock options activity for the three months ended March 31, 2024:
Number of Shares Weighted Average Exercise Price per Share Weighted Average Remaining Contractual Term Aggregate Intrinsic Value
(in thousands) (in years) (in thousands)
Options outstanding at December 31, 2023
684  $ 8.08 
Granted 296  12.42 
Exercised (72) 8.42 
Forfeited —  — 
Options outstanding at March 31, 2024
908  $ 9.47  8.74 $ 4,593 
Options exercisable at March 31, 2024
314  $ 8.38  8.11 $ 1,933 
Schedule of Outstanding RSUs and PSUs
The following table presents a summary of the Company’s outstanding RSUs and PSUs, assuming the current estimated level of performance achievement:
March 31, 2024
(in thousands, except period)
Unvested units 1,293 
Remaining cost on unvested units $ 1,505 
Remaining vesting period 2.75 years